Zentiva
Oleksandr Poljanyčka serves as the Strategy & Transformation Manager at Zentiva, focusing on M&A, corporate finance, and strategic transformation since July 2022. Prior experience includes a role as a Consultant at IQVIA from January 2019 to June 2022, where responsibilities encompassed business development, project management, and topics such as parallel trade and omnichannel implementation across local and regional levels in CEE and EMEA. Earlier roles consist of a Business Analyst and Business Analyst Intern at IQVIA and Deloitte Czech Republic, respectively, emphasizing consulting projects, financial due diligence, and M&A advisory. Oleksandr holds an Ing. degree in Finance and Business Valuation and a Bc. degree in International Trade from the Prague University of Economics and Business.
This person is not in any teams
This person is not in any offices
Zentiva
5 followers
Zentiva is a Pan-European Platform developing, manufacturing and providing high-quality and affordable medicines to more than 100 million people in Europe. Zentiva has 4 wholly owned manufacturing sites and a broad network of external manufacturing partners to ensure supply security. We offer solutions in key therapeutical areas like Cardiology & Circulation, Diabetes, Oncology, Respiratory, CNS and focus on expanding our portfolio in self-care. The company is Private Equity owned, delivering sustainable double-digit growth, with an ambitious 5-year plan for further strong (organic and inorganic) growth across Europe. We are a team of almost 5,000 unique talents bonded together by our mission to deliver high-quality and affordable medicines to people who depend on them every day. We want Zentiva to be a great place to work, where everyone feels welcomed and appreciated and can be their true selves contributing to the best of their ability.